Amylx Pharmaceuticals Inc vs Funko Inc — how do they compare? Amylx Pharmaceuticals Inc trades at $23.96 (market cap $2.64B), while Funko Inc trades at $6.1 (market cap $332.33M). The key difference: Amylx Pharmaceuticals Inc is far larger — about 7.9× Funko Inc's market cap. Which is the better fit depends on your goals.
| AMLX | FNKO | |
|---|---|---|
Market Cap | $2.64B | $332.33M |
Sector | Health | Consumer Staples |
52-Week High | $24.19 | $6.35 |
52-Week Low | $7.82 | $2.65 |
Enterprise Value | $2.39B | $552.98M |
Trailing returns across standard periods
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Read more on AMLX →Funko Inc is a US-based pop culture consumer products company. It creates whimsical, fun, and different products which enable the customer to express their affinity for their favorite through movie, TV show, video game, musician or sports team. The company holds licenses and the rights to create tens of thousands of characters including Game of Thrones, Walking Dead, Disney, Marvel, Harry Potter, Fallout, and others. Its products include Pop, Dorbz, Mystery Vinyl, Plush, Action Figures, and Others. The company sells its products through a diverse network of retail customers across multiple retail channels, including specialty retailers, mass-market retailers, and e-commerce sites.
Read more on FNKO →